https://www.marketscreener.com/quote/stock/SCYNEXIS-INC-16166430/news/SCYNEXIS-Announces-FDA-Approval-of-BREXAFEMME-ibrexafungerp-tablets-as-the-First-and-Only-Oral-N-35511708/?utm_source=telegram&utm_medium=social&utm_campaign=share